1
Cheng Der Yu, Ursula Bruenner: Carbonate diester solutions of PGE-type compounds. Syntex, James M Kanagy, Alan M Krubiner, Tom M Moran, May 4, 1982: US04328245 (136 worldwide citation)

Stable compositions of PGE-type compounds are achieved by dissolving those compounds in carbonate diester solvents which may contain water up to the solubility limit of the carbonate diester.


2
Cheng Der Yu: Propylene glycol diester solutions of PGE-type compounds. Syntex, James M Kanagy, Tom M Moran, October 11, 1983: US04409239 (135 worldwide citation)

Stable compositions of PGE and PGE-type compounds are achieved by dissolving these compounds in propylene glycol diesters of short chain fatty acids.


3
Cheng Der Yu, Ursula Bruenner: Carbonate diester solutions of PGE-type compounds. Syntex, James M Kanagy, Tom M Moran, October 18, 1983: US04410545 (133 worldwide citation)

Stable compositions of PGE-type compounds are achieved by dissolving those compounds in carbonate diester solvents which may contain water up to the solubility limit of the carbonate diester.


4
Roshantha A S Chandraratna: Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity. Allergan, James M Kanagy, Stuart A Suter, March 7, 1989: US04810804 (131 worldwide citation)

Retinoid-like activity is exhibited by compounds of the formula ##STR1## where X is S, O or NR.sub.1 where R.sub.1 is hydrogen or lower alkyl; n is 0-5; R is H or lower alkyl and A is H, --COOH or a pharmaceutically acceptable salt, ester or amide thereof, --CH.sub.2 OH or an ether or ester derivati ...


5
Roshantha A S Chandraratna: Ethynylphenyl-containing retinoic acid derivatives. Allergan, James M Kanagy, April 19, 1988: US04739098 (129 worldwide citation)

Retinoid-like activity is exhibited by compounds of the formula ##STR1## where n is 0-5 and A is H, lower alkyl, or --COOH or ester or amide thereof, --CH.sub.2 OH or an ether or ester derivative, or --CHO or an acetal derivative, or a pharmaceutically acceptable salt.


6
Roshantha A S Chandraratna: Thiochroman esters of phenols and terephthallates having retinoid-like activity. Allergan, James M Kanagy, Martin A Voet, January 23, 1990: US04895868 (124 worldwide citation)

Compounds of formula I ##STR1## in which: the R groups are independently hydrogen or lower alkyl; one of A and B is O or S and the other is --C(O)--, A being attached to the thiochroman ring at the 6 or 7-position;


7
Shabbir T Anik: Polypeptides/chelating agent nasal compositions having enhanced peptide absorption. Syntex, James M Kanagy, Tom M Moran, October 9, 1984: US04476116 (90 worldwide citation)

Disclosed herein are nasal spray compositions and methods for enhancing polypeptide absorption across nasal membranes comprising a chelating agent and a polypeptide in a pharmaceutically acceptable excipient.


8
Cheng Der Yu: Acetal stabilized prostaglandin compositions. Syntex, James M Kanagy, Alan M Krubiner, Tom M Moran, November 9, 1982: US04358603 (88 worldwide citation)

Degradation of prostaglandins in anhydrous or aqueous pharmaceutically acceptable, water-miscible alcohol solutions is prevented by adding a stabilizing amount of a pharmaceutically acceptable acetal.


9
David P O Bryan, Kevin N Constable, Peter J Sagona, Bingham H Van Dyke Jr: Automated sampling and testing of biological materials. SmithKline Beecham Corporation, James M Kanagy, Stephen Venetianer, Edward T Lentz, April 22, 1997: US05623415 (80 worldwide citation)

This invention relates to an automated apparatus for subjecting samples to one or more selected test procedures at one or more test stations comprising a conveyor line for transporting samples contained in uniquely labeled containers, said line having at least two lanes for routing said containers t ...


10
John J Nestor Jr, John G Moffatt, Hardy W Chan: Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture. Syntex, James M Kanagy, Tom M Moran, January 15, 1985: US04493795 (72 worldwide citation)

The present invention relates to novel synthetic antigens, conjugates and antibodies based upon specific peptide sequences and the production thereof. More particularly, the invention relates to a polypeptide which is a determinant site of a protein, the polypeptide having from 8 to 20 amino acid re ...